Mestinon Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
What is Mestinon?
Mestinon is a brand name for the drug Pyridostigmine, a cholinesterase inhibitor used for the treatment of muscle weakness in Myaesthenia Gravis. Mestinon is a brand name owned by Valeant pharmaceuticals.
Read more...
See more information, including instructions, precautions, side effects, and interactions.
Reasons Taken
11 patients in the community are taking or have taken Mestinon.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Other | 6 | 54% |
| Fatigue | 3 | 27% |
| Atrophy, upper body muscles | 1 | 9% |
| disease-related symptoms | 1 | 9% |
| Slow my ALS progress | 1 | 9% |
Dosages
Based on the patients currently taking Mestinon.
Duration
How long current patients have been taking Mestinon or how long patients were taking Mestinon before stopping.
Currently taking Mestinon
Stopped taking Mestinon
Patient Reported Evaluations
Results from 2 patient evaluations. See the overall results and all individual evaluations.
Efficacy (Effect based on reason taken)
| Major | 100% | 1 |
|---|
Insomnia
Side-effects (as an overall problem)
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 0% | 0 |
| Mild | 0% | 0 |
| None | 100% | 2 |
Summary results are based on 2 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Individual Patient Reported Evaluations (1 of 2)
-
- ashfieb
- Mouth/throat: none
- Arms: mild
- Chest: none
- Legs: none
- See profile
-
by ashfieb
Aug 19, 2008
- EfficacyNone
- Side-effectsNone
- Atrophy, upper body muscles
- See full evaluation
-
0 helpful marks